Zobrazeno 1 - 10
of 39
pro vyhledávání: '"A. Brugarolas Masllorens"'
Publikováno v:
Therapeutic Drug Monitoring. 43:447-450
We describe a clinical case of an 84-year-old man diagnosed with non-small cell lung carcinoma and epidermal growth factor receptor mutation, who was treated with erlotinib, with doses adjusted by therapeutic drug monitoring. This case involved a cle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea00cf10d420a92063adf2f0bac122d
https://doi.org/10.1097/ftd.0000000000000894
https://doi.org/10.1097/ftd.0000000000000894
Autor:
Alejandro Paz Yáñez, Rodolfo Martín Diaz, Paula Muñoz Muñoz, Jose Rolando Ortega Ramírez, Pedro Bretcha Boix, Antonio Brugarolas Masllorens
Publikováno v:
European Journal of Surgical Oncology. 49:e94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74c6c36e84a6724c9e578d73923554d1
https://doi.org/10.1016/j.ejso.2022.11.286
https://doi.org/10.1016/j.ejso.2022.11.286
Autor:
Alegre, José Farre, Duarte, Maritza, Sureda González, Manuel, Bretcha Boix, Pere, Dussan, Carlos, Ballester, Antonio, Crespo, Aurora, Brugarolas Masllorens, Antonio
Publikováno v:
In Cirugia Espanola February 2012 90(2):114-120
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Antonio Brugarolas Masllorens, Juan J. Mata-Molanes, Elena Mª Martínez Navarro, Manuel Sureda González, Belén Valenzuela Jiménez
Publikováno v:
Targeted Oncology. 12:289-299
Cytokine-induced killer (CIK) cells form under certain stimulation conditions in cultures of peripheral blood mononuclear cells (PBMCs). They are a heterogeneous immune cell population and contain a high percentage of cells with a mixed T-NK phenotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a604568ce9784334e2b60a27b4069c5
https://doi.org/10.1007/s11523-017-0489-2
https://doi.org/10.1007/s11523-017-0489-2
Autor:
Aurora Crespo-Jara, Maribel Lopera Sierra, Ramon Gonzalez Manzano, María Carmen Redal Peña, Antonio Brugarolas Masllorens
Publikováno v:
Clinical Nuclear Medicine
We present a sarcoma patient with a tumor reduction of more than 50% in lung metastasis after 2 single courses of the investigational medical product Lutathera (177Lu-DOTA0-Tyr3-octreotate). She was resistant to more than 6 lines of therapy including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04dbf1d55e525dd4cf5ddad2fa73bb80
https://doi.org/10.1097/rlu.0000000000001288
https://doi.org/10.1097/rlu.0000000000001288
Autor:
Antonio Brugarolas Masllorens, Manuel Sureda, Juan José Pérez Ruixo, Pedro Bretcha-Boix, Carlos Dussan, José Farré-Alegre
Publikováno v:
Clinical and Translational Oncology. 12:437-442
Peritoneal carcinomatosis is a relatively frequent situation in the natural history of colorectal cancer and is associated with a dismal prognosis. Promising results have been shown after radical cytoreduction followed by intraperitoneal chemohyperth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ec9372f584dd6a2f8460d8970f3b05
https://doi.org/10.1007/s12094-010-0531-7
https://doi.org/10.1007/s12094-010-0531-7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ramón Arcas Meca, Aurora Crespo de la Jara, Timo L.M. ten Hagen, Antonio Brugarolas Masllorens, Emiliano Calvo Aller, Alexander M.M. Eggermont
Publikováno v:
Revista de Oncología. 5:128-138
La perfusion de extremidad aislada (PEA) con melfalan es activa en el tratamiento de las metastasis en transito de melanoma, pero no ha mostrado eficacia en el de sarcomas de partes blandas irresecables de extremidad. Esta situacion se ha visto modif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be165a6adf6ff1be0fe903866abdeb4c
https://doi.org/10.1007/bf02712847
https://doi.org/10.1007/bf02712847
Autor:
A. Brugarolas Masllorens, Aurora Crespo-Jara, J. Muñoz Iglesias, Joseba Rebollo, F.J. Pena Pardo, M.C. Redal Peña
Publikováno v:
Revista Española de Medicina Nuclear. 30:248-250
Resumen La PET-TAC con FDG se ha convertido en una herramienta imprescindible en el manejo del paciente oncologico. La distribucion normal de la FDG y los posibles artefactos (pitfalls), incluidos aquellos derivados de la correccion de atenuacion bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fda28ae0b86a19ab2672f4f283182d42
https://doi.org/10.1016/j.remn.2010.07.007
https://doi.org/10.1016/j.remn.2010.07.007